Short answer
Commercial production strategies for pharmaceuticals must account for the lifecycle and market dynamics of essential drugs, including the economic and regulatory challenges that can lead to product unavailability and market failure.
- Field
- Commercial Production
- Source
- Infection and Drug Resistance (2018)
- Method
- Literature Review
- Evidence
- Moderate effect
The decline in new antibiotic development, driven by regulatory hurdles and low financial incentives, leads to a market where existing drugs are overused, increasing resistance and ultimately impacting the economic viability of pharmaceutical production. This commercial production research insight is drawn from a 2018 study published in Infection and Drug Resistance. Using Literature review, researchers explored how this design variable affects real-world outcomes. The key design takeaway: Commercial production strategies for pharmaceuticals must account for the lifecycle and market dynamics of essential drugs, including the economic and regulatory challenges that can lead to product unavailability and market failure.
Antibiotic Unavailability Increases Production Costs and Market Risk
The decline in new antibiotic development, driven by regulatory hurdles and low financial incentives, leads to a market where existing drugs are overused, increasing resistance and ultimately impacting the economic viability of pharmaceutical production.
Infection and Drug Resistance · 2018
Key Findings
- 01Multidrug resistance is diminishing the effectiveness of existing antibiotics.
- 02The development of new antibiotics is hampered by stringent regulatory requirements and reduced financial incentives for pharmaceutical companies.
- 03Misuse of current antibiotics contributes significantly to the rise of resistance.
- 04Alternative therapies like probiotics, antibodies, and vaccines show promise but require further development and integration.
Application
Design takeaway
Commercial production strategies for pharmaceuticals must account for the lifecycle and market dynamics of essential drugs, including the economic and regulatory challenges that can lead to product unavailability and market failure.
How to apply
Consider the economic and regulatory landscape when designing and planning the production of any product that relies on a complex supply chain or faces significant market access challenges.
Project actions
- 01When considering a product for your project, research the market and regulatory environment it operates within.
- 02Think about how economic factors might influence the production and availability of your chosen product.
- 03Explore how innovation in materials or manufacturing processes could address market challenges.
Method & Evidence
Variables
Strengths & Limitations
Strengths
- +Provides a high-level overview of a critical global issue with direct commercial production implications.
- +Connects scientific challenges (resistance) with economic and regulatory factors.
Limitations
The economic models and regulatory frameworks discussed are complex and may vary significantly by region. The focus is on pharmaceuticals, so direct application to other product types might require adaptation.
Reliability & validity
The reliability of the findings depends on the quality and breadth of the literature reviewed. Validity is strong in identifying the problem but may be limited in offering specific, universally applicable commercial solutions.
Think critically
To what extent should governments intervene to ensure the commercial production of essential but less profitable goods like new antibiotics?
Design Principles
"Economic viability of essential product development is contingent upon balancing innovation incentives with public health needs and regulatory frameworks."
This highlights the complex interplay between product development, market forces, and public health within the commercial production landscape. For design, it underscores how economic factors and regulatory environments can directly influence the availability and sustainability of essential products, impacting manufacturing strategies and long-term market success.
What This Means for Your Design
Making new medicines, like antibiotics, is expensive and difficult because of strict rules and not much money to be made, which means we don't have enough new ones when old ones stop working.
How to use in your project
- 1.Use this insight to justify the need for a new product or an improved design by highlighting market gaps or production challenges.
- 2.Discuss the economic viability and potential market risks associated with your design concept.
- 3.Analyze how regulatory requirements might affect your manufacturing process.
Add to My Project
Quick Cite
Paragraph starter
The development and commercial production of essential pharmaceuticals, such as antibiotics, are significantly impacted by the economic viability of innovation and stringent regulatory pathways. As highlighted by the global antibiotic resistance crisis, a lack of financial incentives and complex approval processes can lead to a scarcity of new drugs, increasing the reliance on and misuse of existing ones. This creates a challenging market environment where the long-term sustainability of production is threatened by the very public health crisis it aims to address, necessitating a re-evaluation of commercial strategies to balance profit motives with societal needs.
Source
Infection and Drug Resistance
Antibiotic resistance: a rundown of a global crisis
journal · 2018
View sourceQuestions About This Research
- What does the research say about antibiotic unavailability increases production costs and market risk?
- Commercial production strategies for pharmaceuticals must account for the lifecycle and market dynamics of essential drugs, including the economic and regulatory challenges that can lead to product unavailability and market failure. Evidence: Infection and Drug Resistance (2018).
- Why does "Antibiotic Unavailability Increases Production Costs and Market Risk" matter for design?
- This highlights the complex interplay between product development, market forces, and public health within the commercial production landscape. For IB DT, it underscores how economic factors and regulatory environments can directly influence the availability and sustainability of essential products, impacting manufacturing strategies and long-term market success.
- How can designers apply this research?
- Commercial production strategies for pharmaceuticals must account for the lifecycle and market dynamics of essential drugs, including the economic and regulatory challenges that can lead to product unavailability and market failure.
- What were the main findings?
- Multidrug resistance is diminishing the effectiveness of existing antibiotics.. The development of new antibiotics is hampered by stringent regulatory requirements and reduced financial incentives for pharmaceutical companies.. Misuse of current antibiotics contributes significantly to the rise of resistance.. Alternative therapies like probiotics, antibodies, and vaccines show promise but require further development and integration.
- What research method was used?
- Literature Review.
- How strong is the evidence?
- Evidence strength is rated Moderate effect, based on a 2018 journal from Infection and Drug Resistance.
- What should I do differently in my next project?
- Consider the economic and regulatory landscape when designing and planning the production of any product that relies on a complex supply chain or faces significant market access challenges.
- What are the limitations?
- The paper is a review and does not present new experimental data. It focuses primarily on the causes and consequences of antibiotic resistance rather than specific commercial production techniques.